FDA officials explain how to ensure registries generate fit-for-purpose data | RAPS
Regulatory NewsJoanne S. EglovitchAdvanced therapies/cell and gene therapyBiologics/ biosimilars/ vaccinesBiotechnologyClinical TrialsPharmaceuticalsProduct developmentRegulatory Intelligence/PolicyResearch, Design and DevelopmentRWE/RWDUnited StatesUS Food and Drug Administration (FDA)
